Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology

Full Article
Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology

Bioptimus has achieved a significant funding milestone of $76 million, with a recent $41 million investment led by Cathay Innovation. This funding will support the development of a groundbreaking multi-scale, multi-modal AI foundation model for biology, set to launch in 2025. The model aims to transform research across various industries, including medical, biotech, and cosmetics.

The company has already made strides with its first model, H-Optimus-0, which is the largest AI foundation model for pathology. This model has demonstrated superior performance in predicting gene expression and subtyping ovarian cancer. By integrating diverse biological data, Bioptimus is breaking down traditional silos in biological research, paving the way for innovative solutions in healthcare and beyond.

• Bioptimus raises $76 million to enhance AI-driven biological research.

• H-Optimus-0 model outperforms existing pathology models in independent benchmarks.

Key AI Terms Mentioned in this Article

AI Foundation Model

The AI foundation model serves as a comprehensive framework for simulating biological processes across various scales.

Multi-modal AI

Multi-modal AI integrates diverse data types, such as imaging and genetics, to provide a holistic view of biology.

Pathology Model

The pathology model, H-Optimus-0, excels in predicting gene expression and cancer subtypes with high accuracy.

Companies Mentioned in this Article

Bioptimus

Bioptimus focuses on developing AI foundation models to revolutionize biological research and innovation.

Cathay Innovation

Cathay Innovation is a venture capital firm that supports transformative AI businesses, including Bioptimus.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics